Listen to audio brief:
On May 12, 2025, the White House announced a new executive order aimed at establishing most-favored-nation pricing for prescription drugs in the United States. This order addresses the disparity in drug pricing, as Americans often pay significantly more for medications than consumers in other developed countries. The administration plans to collaborate with various agencies to ensure that American patients receive competitive prices for their medications, tackling issues of price discrimination and striving to align U.S. drug prices with those in comparable nations.
Original: article









